All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

AKIN GUMP STRAUSS HAUER & FELD filed a Q4 report for CHRISTUS HEALTH SYSTEM on January 20, 2026, reporting $110,000 in lobbying income.

Lobbying for CHRISTUS HEALTH SYSTEM · Catholic health system health care provider

All filings by AKIN GUMP STRAUSS HAUER & FELD · Everything CHRISTUS HEALTH SYSTEM has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$110,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 2

TRUMAN REED New on this filing

Previously held: Dpty. CoS, Leg. Dir., Rep. De La Cruz (2023-2025); Leg. Asst. Rep. De La Cruz (2023); Leg. Asst. Rep. Young (2018-2020, 2020-2021); LC Rep. Young (2018); Intrn Sen. Sullivan (2017); Intrn Sen. Whitehouse (2016)
JOCELYN WILES New on this filing

Previously held: Staffer, Rep. Kathy Castor (Jan. 07 - Feb. 11); Intern/Fellow, Rep. Barbara Lee (2006); Intern, Rep. Danny Davis (2004).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce.

Medicare/Medicaid

Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to 1115 Medicaid Waivers; Issues related to maternal health, freestanding ERs, and the health care workforce; Issues related to Medicaid coverage and enrollees.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.